SOFIA (Bulgaria), October 4 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday its sales revenue rose by an annual 16% in the first nine months of 2017.
On the domestic market, the company’s sales grew 2% year-on-year in January-September, while exports increased 25%, Sopharma said in a bourse filing without providing figures for the value of its sales.
In September alone, Sopharma’s sales revenue rose 8% year-on-year.
Sopharma, Bulgaria's biggest drug maker, has subsidiaries in Moldova, Russia, Serbia, Belarus, Poland, Latvia, Lithuania, Ukraine and Kazakhstan.
As at 1430 CET on Wednesday, Sopharma shares traded 1.86% higher at 4.339 levs ($2.61/2.22 euro).
(1 euro=1.95583 levs)